Maternal immune activation causes age- and region-specific changes in brain cytokines in offspring throughout development

Brain, Behavior, and Immunity

Volumn 31, Issue , 2013, Pages 54-68

  Garay, Paula A ^a   Hsiao, Elaine Y ^b   Patterson, Paul H ^b   McAllister, A K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Autism; Chemokine; Development; Inflammation; Maternal infection; Microglia; Neuroimmunology; Poly(I:C); Schizophrenia; Serum

Indexed keywords

EOTAXIN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTISM; BEHAVIOR DISORDER; BRAIN DEVELOPMENT; BRAIN LEVEL; BRAIN REGION; CINGULATE GYRUS; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; HIPPOCAMPUS; IMMUNOSTIMULATION; MALE; MATERNAL DISEASE; MATERNAL IMMUNE ACTIVATION; MATERNAL INFECTION; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROGENY; PROTEIN BLOOD LEVEL; RISK FACTOR; SCHIZOPHRENIA; SYNAPTOGENESIS;

AGE FACTORS; ANIMALS; BEHAVIOR, ANIMAL; BLOOD-BRAIN BARRIER; BRAIN; CYTOKINES; FEMALE; MICE; ORGAN SPECIFICITY; POLY I-C; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; STARTLE REACTION;

EID: 84877352822     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2012.07.008     Document Type: Article

References (81)

1. Abazyan B., Nomura J., Kannan G., Ishizuka K., Tamashiro K.L., Nucifora F., Pogorelov V., Ladenheim B., Yang C., Krasnova I.N., Cadet J.L., Pardo C., Mori S., Kamiya A., Vogel M.W., Sawa A., Ross C.A., Pletnikov M.V. Prenatal interaction of mutant DISC1 and immune activation produces adult psychopathology. Biol Psychiatry 2010, 68:1172-1181.
2. Arrode-Bruses G., Bruses J.L. Maternal immune activation by poly(I:C) induces expression of cytokines IL-1beta and IL-13, chemokine MCP-1 and colony stimulating factor VEGF in fetal mouse brain. J Neuroinflammation 2012, 9:83.
3. Ashwood P., Krakowiak P., Hertz-Picciotto I., Hansen R., Pessah I., Van de Water J. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav. Immun. 2011, 25:40-45.
4. Ashwood P., Krakowiak P., Hertz-Picciotto I., Hansen R., Pessah I.N., Van de Water J. Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders. J. Neuroimmunol. 2011, 232:196-199.
5. Ashwood P., Nguyen D.V., Hessl D., Hagerman R.J., Tassone F. Plasma cytokine profiles in Fragile X subjects: is there a role for cytokines in the pathogenesis?. Brain Behav. Immun. 2010, 24:898-902.
6. Atladottir H.O., Thorsen P., Ostergaard L., Schendel D.E., Lemcke S., Abdallah M., Parner E.T. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J. Autism Dev. Disord. 2010, 40:1423-1430.
7. Bauer S., Kerr B.J., Patterson P.H. The neuropoietic cytokine family in development, plasticity, disease and injury. Nat. Rev. Neurosci. 2007, 8:221-232.
8. Bauman, M.D., Iosif, A.-M., Smith, S., Bregere, M., Zadran, S., Amaral, D.G., Patterson, P.H., 2011. A nonhuman primate model of maternal immune activation. Annual Society for Neuroscience Meeting Abs. 778.06.
9. Brown, A.S., 2012. Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism. Dev Neurobiol. [Epub ahead of print]. doi:10.1002/dneu.22024.
10. Brown A.S., Begg M.D., Gravenstein S., Schaefer C.A., Wyatt R.J., Bresnahan M., Babulas V.P., Susser E.S. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch. Gen. Psychiatry 2004, 61:774-780.
11. Brown A.S., Derkits E.J. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. The American journal of psychiatry 2010, 167:261-280.
12. Brown A.S., Patterson P.H. Maternal infection and schizophrenia: implications for prevention. Schizophr. Bull. 2011, 37:284-290.
13. Careaga M., Van de Water J., Ashwood P. Immune dysfunction in autism: a pathway to treatment. Neurotherapeutics 2010, 7:283-292.
14. Chez M.G., Dowling T., Patel P.B., Khanna P., Kominsky M. Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children. Pediatr. Neurol. 2007, 36:361-365.
15. Clancy B., Finlay B.L., Darlington R.B., Anand K.J. Extrapolating brain development from experimental species to humans. Neurotoxicology 2007, 28:931-937.
16. Dalgard C.L., Cole J.T., Kean W.S., Lucky J.J., Sukumar G., McMullen D.C., Pollard H.B., Watson W.D. The cytokine temporal profile in rat cortex after controlled cortical impact. Front Mol. Neurosci. 2012, 5:6.
17. Datta S.C., Opp M.R. Lipopolysaccharide-induced increases in cytokines in discrete mouse brain regions are detectable using Luminex xMAP technology. J. Neurosci. Methods 2008, 175:119-124.
18. David S., Kroner A. Repertoire of microglial and macrophage responses after spinal cord injury. Nat. Rev. Neurosci. 2011, 12:388-399.
19. Davis J.O., Phelps J.A., Bracha H.S. Prenatal development of monozygotic twins and concordance for schizophrenia. Schizophr Bull. 1995, 21:357-366.
20. Deverman B.E., Patterson P.H. Cytokines and CNS development. Neuron 2009, 64:61-78.
21. Erickson M.A., Banks W.A. Cytokine and chemokine responses in serum and brain after single and repeated injections of lipopolysaccharide: multiplex quantification with path analysis. Brain Behav. Immun. 2011, 25:1637-1648.
22. Fatemi S.H., Emamian E.S., Sidwell R.W., Kist D.A., Stary J.M., Earle J.A., Thuras P. Human influenza viral infection in utero alters glial fibrillary acidic protein immunoreactivity in the developing brains of neonatal mice. Mol. Psychiatry 2002, 7:633-640.
23. Fatemi S.H., Reutiman T.J., Folsom T.D., Huang H., Oishi K., Mori S., Smee D.F., Pearce D.A., Winter C., Sohr R., Juckel G. Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: implications for genesis of neurodevelopmental disorders. Schizophr Res. 2008, 99:56-70.
24. Fatemi S.H., Sidwell R., Kist D., Akhter P., Meltzer H.Y., Bailey K., Thuras P., Sedgwick J. Differential expression of synaptosome-associated protein 25kDa [SNAP-25] in hippocampi of neonatal mice following exposure to human influenza virus in utero. Brain Res. 1998, 800:1-9.
25. Feng J.F., Van K.C., Gurkoff G.G., Kopriva C., Olszewski R.T., Song M., Sun S., Xu M., Neale J.H., Yuen P.W., Lowe D.A., Zhou J., Lyeth B.G. Post-injury administration of NAAG peptidase inhibitor prodrug, PGI-02776, in experimental TBI. Brain Res. 2011, 1395:62-73.
26. Focking M., Dicker P., English J.A., Schubert K.O., Dunn M.J., Cotter D.R. Common proteomic changes in the hippocampus in schizophrenia and bipolar disorder and particular evidence for involvement of cornu ammonis regions 2 and 3. Arch. Gen. Psychiatry. 2011, 68:477-488.
27. Fu Q., Zhu J., Van Eyk J.E. Comparison of multiplex immunoassay platforms. Clin. Chem. 2010, 56:314-318.
28. Gandhi R., Hayley S., Gibb J., Merali Z., Anisman H. Influence of poly I:C on sickness behaviors, plasma cytokines, corticosterone and central monoamine activity: moderation by social stressors. Brain Behav. Immun. 2007, 21:477-489.
29. Garay P.A., McAllister A.K. Novel roles for immune molecules in neural development: implications for neurodevelopmental disorders. Frontiers synaptic neurosci. 2010, 2(136):1-16.
30. Gilmore J.H., Jarskog L.F., Vadlamudi S. Maternal poly I:C exposure during pregnancy regulates TNF alpha, BDNF, and NGF expression in neonatal brain and the maternal-fetal unit of the rat. J Neuroimmunol 2005, 159:106-112.
31. Gilmore J.H., Jarskog L.F., Vadlamudi S., Lauder J.M. Prenatal infection and risk for schizophrenia: IL-1b, IL-6, and TNFa inhibit cortcial neuron dendrtie development. Neuropsychopharmacology 2004, 29:1221-1229.
32. Goines P.E., Croen L.A., Braunschweig D., Yoshida C.K., Grether J., Hansen R., Kharrazi M., Ashwood P., Van de Water J. Increased midgestational IFN-gamma, IL-4 and IL-5 in women bearing a child with autism: a case-control study. Mol. Autism. 2011, 2:13.
33. Hagberg H., Gressens P., Mallard C. Inflammation during fetal and neonatal life: implications for neurologic and neuropsychiatric disease in children and adults. Ann. Neurol. 2012, 71:444-457.
34. Hallmayer, J., Cleveland, S., Torres, A., Phillips, J., Cohen, B., Torigoe, T., Miller, J., Fedele, A., Collins, J., Smith, K., Lotspeich, L., Croen, L.A., Ozonoff, S., Lajonchere, C., Grether, J.K., Risch, N., 2011. Genetic Heritability and Shared Environmental Factors Among Twin Pairs With Autism. Arch. Gen. Psychiatry. 1095-1012.
35. Hsiao E.Y., Patterson P.H. Activation of the maternal immune system induces endocrine changes in the placenta via IL-6. Brain Behav. Immun. 2011, 25:604-615.
36. Ito H.T., Smith S.E.P., Hsiao E., Patterson P.H. Maternal immune activation alters nonspatial information processing in the hippocampus of adult offspring. Brain Behav. Immun. 2010, 24:930-941.
37. Ji L., Chauhan V., Flory M.J., Chauhan A. Brain region-specific decrease in the activity and expression of protein kinase A in the frontal cortex of regressive autism. PLoS One 2011, 6:e23751.
38. Johnson E.A., Kan R.K. The acute phase response and soman-induced status epilepticus: temporal, regional and cellular changes in rat brain cytokine concentrations. J Neuroinflammation 2010, 7:40.
39. Juttler E., Tarabin V., Schwaninger M. Interleukin-6 (IL-6): a possible neuromodulator induced by neuronal activity. Neuroscientist 2002, 8:268-275.
40. Kasten-Jolly J., Heo Y., Lawrence D.A. Central nervous system cytokine gene expression: modulation by lead. J. Biochem. Mol. Toxicol. 2011, 25:41-54.
41. Koga K., Cardenas I., Aldo P., Abrahams V.M., Peng B., Fill S., Romero R., Mor G. Activation of TLR3 in the trophoblast is associated with preterm delivery. Am. J. Reprod Immunol. 2009, 61:196-212.
42. Kogan M.D., Blumberg S.J., Schieve L.A., Boyle C.A., Perrin J.M., Ghandour R.M., Singh G.K., Strickland B.B., Trevathan E., van Dyck P.C. Prevalence of parent-reported diagnosis of autism spectrum disorder among children in the US, 2007. Pediatrics 2009, 124:1395-1403.
43. Kunz M., Cereser K.M., Goi P.D., Fries G.R., Teixeira A.L., Fernandes B.S., Belmonte-de-Abreu P.S., Kauer-Sant'anna M., Kapczinski F., Gama C.S. Serum levels of IL-6, IL-10 and TNF-alpha in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance. Rev. Bras. Psiquiatr. 2011, 33:268-274.
44. Li X., Chauhan A., Sheikh A.M., Patil S., Chauhan V., Li X.M., Ji L., Brown T., Malik M. Elevated immune response in the brain of autistic patients. J. Neuroimmunol. 2009, 207:111-116.
45. Lord C., Cook E.H., Leventhal B.L., Amaral D.G. Autism spectrum disorders. Neuron 2000, 28:355-363.
46. Malkova N.V., Yu C.Z., Hsiao E.Y., Moore M.J., Patterson P.H. Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism. Brain Behav. Immun. 2012, 26:607-616.
47. Mandal M., Marzouk A.C., Donnelly R., Ponzio N.M. Maternal immune stimulation during pregnancy affects adaptive immunity in offspring to promote development of TH17 cells. Brain Behav. Immun. 2011, 25:863-871.
48. McAfoose J., Baune B.T. Evidence for a cytokine model of cognitive function. Neurosci. Biobehav. Rev. 2009, 33:355-366.
49. Meyer U., Feldon J. Epidemiology-driven neurodevelopmental animal models of schizophrenia. Prog. Neurobiol. 2010, 90:285-326.
50. Meyer U., Feldon J., Dammann O. Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation?. Pediatr. Res. 2011, 69:26R-33R.
51. Meyer U., Feldon J., Fatemi S.H. In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders. Neurosci. Biobehav. Rev. 2009, 33:1061-1079.
52. Meyer U., Feldon J., Schedlowski M., Yee B.K. Immunological stress at the maternal-foetal interface. a link between neurodevelopment and adult psychopathology. Brain Behav. Immun. 2006, 20:378-388.
53. Meyer U., Knuesel I., Nyffeler M., Feldon J. Chronic clozapine treatment improves prenatal infection-induced working memory deficits without influencing adult hippocampal neurogenesis. Psychopharmacology (Berl) 2010, 208:531-543.
54. Meyer U., Nyffeler M., Engler A., Urwyler A., Schedlowski M., Knuesel I., Yee B.K., Feldon J. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J. Neurosci. 2006, 26:4752-4762.
55. Meyer U., Nyffeler M., Schwendener S., Knuesel I., Yee B.K., Feldon J. Relative prenatal and postnatal maternal contributions to schizophrenia-related neurochemical dysfunction after in utero immune challenge. Neuropsychopharmacology 2008, 33:441-456.
56. Meyer U., Schwendener S., Feldon J., Yee B.K. Prenatal and postnatal maternal contributions in the infection model of schizophrenia. Exp. Brain Res. 2006, 173:243-257.
57. Molloy C.A., Morrow A.L., Meinzen-Derr J., Schleifer K., Dienger K., Manning-Courtney P., Altaye M., Wills-Karp M. Elevated cytokine levels in children with autism spectrum disorder. J. Neuroimmunol. 2006, 172:198-205.
58. Mukherjee S., Katki K., Arisi G.M., Foresti M.L., Shapiro L.A. Early TBI-induced cytokine alterations are similarly detected by two distinct methods of multiplex assay. Front Mol. Neurosci. 2011, 4:21.
59. Nawa H., Takahashi M., Patterson P.H. Cytokine and growth factor involvement in schizophrenia-support for the developmental model. Mol. Psychiatry 2000, 5:594-603.
60. Pardo C.A., Vargas D.L., Zimmerman A.W. Immunity, neuroglia and neuroinflammation in autism. Int. Rev. Psychiatry 2005, 17:485-495.
61. Patterson P.H. Neuroscience. Maternal effects on schizophrenia risk. Science 2007, 318:576-577.
62. Patterson P.H. Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav. Brain Res. 2009, 204:313-321.
63. Patterson P.H. Maternal infection and immune involvement in autism. Trends Mol. Med. 2011, 17:389-394.
64. Patterson P.H. Modeling autistic features in animals. Pediatr. Res. 2011, 69:34R-40R.
65. Piontkewitz Y., Assaf Y., Weiner I. Clozapine administration in adolescence prevents postpubertal emergence of brain structural pathology in an animal model of schizophrenia. Biol. Psychiatry 2009, 66:1038-1046.
66. Ransohoff R.M., Perry V.H. Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol. 2009, 27:119-145.
67. Rapoport J., Chavez A., Greenstein D., Addington A., Gogtay N. Autism spectrum disorders and childhood-onset schizophrenia: clinical and biological contributions to a relation revisited. J. Am. Acad. Child Adolesc Psychiatry 2009, 48:10-18.
68. Rosenberg R.E., Law J.K., Yenokyan G., McGready J., Kaufmann W.E., Law P.A. Characteristics and concordance of autism spectrum disorders among 277 twin pairs. Arch. Pediatr. Adolesc Med. 2009, 163:907-914.
69. Shi L., Fatemi S.H., Sidwell R.W., Patterson P.H. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J. Neurosci. 2003, 23:297-302.
70. Shi L., Smith S.E., Malkova N., Tse D., Su Y., Patterson P.H. Activation of the maternal immune system alters cerebellar development in the offspring. Brain Behav. Immun. 2009, 23:116-123.
71. Shi L., Tu N., Patterson P.H. Maternal influenza infection is likely to alter fetal brain development indirectly: the virus is not detected in the fetus. Int. J. Dev. Neurosci. 2005, 23:299-305.
72. Short S.J., Lubach G.R., Karasin A.I., Olsen C.W., Styner M., Knickmeyer R.C., Gilmore J.H., Coe C.L. Maternal influenza infection during pregnancy impacts postnatal brain development in the rhesus monkey. Biol. Psychiatry 2010, 67:965-973.
73. Smith S.E., Li J., Garbett K., Mirnics K., Patterson P.H. Maternal immune activation alters fetal brain development through interleukin-6. J. Neurosci. 2007, 27:10695-10702.
74. Stellwagen D. The contribution of TNFalpha to synaptic plasticity and nervous system function. Adv. Exp. Med. Biol. 2011, 691:541-557.
75. Suda S., Iwata K., Shimmura C., Kameno Y., Anitha A., Thanseem I., Nakamura K., Matsuzaki H., Tsuchiya K.J., Sugihara G., Iwata Y., Suzuki K., Koizumi K., Higashida H., Takei N., Mori N. Decreased expression of axon-guidance receptors in the anterior cingulate cortex in autism. Mol. Autism. 2011, 2:14.
76. Szatmari P. Is Autism, at Least in Part, a Disorder of Fetal Programming?. Arch. Gen. Psychiatry 2011, 68:1091-1092.
77. Toyooka K., Watanabe Y., Iritani S., Shimizu E., Iyo M., Nakamura R., Asama K., Makifuchi T., Kakita A., Takahashi H., Someya T., Nawa H. A decrease in interleukin-1 receptor antagonist expression in the prefrontal cortex of schizophrenic patients. Neurosci. Res. 2003, 46:299-307.
78. Traynor T.R., Majde J.A., Bohnet S.G., Krueger J.M. Intratracheal double-stranded RNA plus interferon-gamma: a model for analysis of the acute phase response to respiratory viral infections. Life Sci. 2004, 74:2563-2576.
79. Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W., Pardo C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 2005, 57:67-81.
80. Weiner I. The " two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment. Psychopharmacology (Berl) 2003, 169:257-297.
81. Yao J.K., Sistilli C.G., van Kammen D.P. Membrane polyunsaturated fatty acids and CSF cytokines in patients with schizophrenia. Prostaglandins, leukotrienes, and essential fatty acids 2003, 69:429-436.